These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 15824276)

  • 1. Survival in Alzheimer disease.
    Lesser GT
    Arch Neurol; 2005 Apr; 62(4):689; author reply 689-90. PubMed ID: 15824276
    [No Abstract]   [Full Text] [Related]  

  • 2. Rate of progression differs in frontotemporal dementia and Alzheimer disease.
    Rascovsky K; Salmon DP; Lipton AM; Leverenz JB; DeCarli C; Jagust WJ; Clark CM; Mendez MF; Tang-Wai DF; Graff-Radford NR; Galasko D
    Neurology; 2005 Aug; 65(3):397-403. PubMed ID: 16087904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease.
    Williams MM; Xiong C; Morris JC; Galvin JE
    Neurology; 2006 Dec; 67(11):1935-41. PubMed ID: 17159097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease.
    Bhargava D; Weiner MF; Hynan LS; Diaz-Arrastia R; Lipton AM
    J Geriatr Psychiatry Neurol; 2006 Jun; 19(2):78-82. PubMed ID: 16690992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline.
    Panza F; Capurso C; D'Introno A; Colacicco AM; Capurso A; Solfrizzi V; Bennett
    Neurology; 2007 Mar; 68(12):964; author replly 964-5. PubMed ID: 17372143
    [No Abstract]   [Full Text] [Related]  

  • 6. Smoking affects the phenotype of Alzheimer disease.
    Sabbagh MN; Tyas SL; Emery SC; Hansen LA; Alford MF; Reid RT; Tiraboschi P; Thal LJ
    Neurology; 2005 Apr; 64(7):1301-3. PubMed ID: 15824373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
    Gauthier S; Poirier J
    Alzheimers Dement; 2009 Mar; 5(2):147-8. PubMed ID: 19328447
    [No Abstract]   [Full Text] [Related]  

  • 8. NSAID exposure and risk of Alzheimer disease: is timing everything?
    Bennett DA; Whitmer RA
    Neurology; 2009 Jun; 72(22):1884-5. PubMed ID: 19386996
    [No Abstract]   [Full Text] [Related]  

  • 9. Mortality derived from 5-year survival in patients with Alzheimer disease.
    Singer RB
    J Insur Med; 2005; 37(4):264-71. PubMed ID: 16459949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pass the grain; spare the brain.
    Galvin JE
    Neurology; 2007 Sep; 69(11):1072-3. PubMed ID: 17846407
    [No Abstract]   [Full Text] [Related]  

  • 11. Change in body mass index and risk of incident Alzheimer disease.
    Buchman AS; Wilson RS; Bienias JL; Shah RC; Evans DA; Bennett DA
    Neurology; 2005 Sep; 65(6):892-7. PubMed ID: 16186530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Alzheimer disease risk by functional magnetic resonance imaging.
    Fleisher AS; Houston WS; Eyler LT; Frye S; Jenkins C; Thal LJ; Bondi MW
    Arch Neurol; 2005 Dec; 62(12):1881-8. PubMed ID: 16344346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset dementia is associated with higher mortality.
    Koedam EL; Pijnenburg YA; Deeg DJ; Baak MM; van der Vlies AE; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2008; 26(2):147-52. PubMed ID: 18679029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression.
    Rapp MA; Schnaider-Beeri M; Grossman HT; Sano M; Perl DP; Purohit DP; Gorman JM; Haroutunian V
    Arch Gen Psychiatry; 2006 Feb; 63(2):161-7. PubMed ID: 16461859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2005 Nov; 65(9):1436-41. PubMed ID: 16275832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease.
    Brickell KL; Steinbart EJ; Rumbaugh M; Payami H; Schellenberg GD; Van Deerlin V; Yuan W; Bird TD
    Arch Neurol; 2006 Sep; 63(9):1307-11. PubMed ID: 16966510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease.
    Shiino A; Watanabe T; Maeda K; Kotani E; Akiguchi I; Matsuda M
    Neuroimage; 2006 Oct; 33(1):17-26. PubMed ID: 16904912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease.
    Geerlings MI; den Heijer T; Koudstaal PJ; Hofman A; Breteler MM
    Neurology; 2008 Apr; 70(15):1258-64. PubMed ID: 18391157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence and impact of comorbidity diagnosed after the onset of head and neck cancer.
    Yung KC; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1045-9. PubMed ID: 18936348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
    Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
    Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.